Lataa...
Long-term results of topical 0.02% tacrolimus ointment for refractory ocular surface inflammation in pediatric patients
BACKGROUND: No studies have been reported on the efficacy and safety of long-term (≥12 months) use of topical tacrolimus for refractory ocular surface inflammation in pediatric patients. METHODS: Medical records of pediatric patients who were prescribed topical 0.02% tacrolimus ointment for refracto...
Tallennettuna:
| Julkaisussa: | BMC Ophthalmol |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8178927/ https://ncbi.nlm.nih.gov/pubmed/34088281 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-021-01998-0 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|